SCHEMBL28293421

SCHEMBL28293421

NN1C(=O)CCC(C(=O)OCc2ccccc2)C1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
CYP2C19 P33261 2/20 0.43
FKBP1A P62942 2/20 0.43
HPGD P15428 1/20 0.43
CHRM2 P08172 1/20 0.42
CHRM4 P08173 1/20 0.42
CHRM5 P08912 1/20 0.42
CHRM1 P11229 1/20 0.42
CHRM3 P20309 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41
F2 P00734 1/20 0.41
FABP7 O15540 1/20 0.41
FABP5 Q01469 1/20 0.41
ELANE P08246 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7383290 0.81 MEN1 (0.54) MEN1KMT2ASMN1; SMN2CYP2C19FKBP1A
SCHEMBL28122831 0.81 MEN1 (0.54) MEN1KMT2ASMN1; SMN2CYP2C19FKBP1A
SCHEMBL4259466 0.80 FAAH (0.40) KMT2ASMN1; SMN2CYP2C19HPGD
SCHEMBL988117 0.79 TSHR (0.51) KMT2ASMN1; SMN2CYP2C19FKBP1ACHRM2
SCHEMBL11285653 0.78 CHRM2 (0.48) MEN1KMT2ASMN1; SMN2CYP2C19FKBP1A
SCHEMBL11285648 0.78 CHRM2 (0.48) MEN1KMT2ASMN1; SMN2CYP2C19FKBP1A
SCHEMBL10760225 0.77 CYP3A4 (0.43) CYP2C19FKBP1AHPGDCHRM2CHRM4
SCHEMBL10924315 0.77 CYP3A4 (0.43) CYP2C19FKBP1AHPGDCHRM2CHRM4
SCHEMBL10760228 0.77 CYP3A4 (0.43) CYP2C19FKBP1AHPGDCHRM2CHRM4
SCHEMBL30986395 0.76 MEN1 (0.54) MEN1KMT2ASMN1; SMN2CYP2C19FKBP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109776493-A A kind of preparation method of lenalidomide 石家庄度恩医药科技有限公司 2019-05-21 CN disclosed